PTC
TNDM icon

Private Trust Company’s Tandem Diabetes Care TNDM Stock Holding History

Private Trust Company’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-93
Closed -$1.72K – 2667
2025
Q2 		$1.72K Sell
93
-92
-50% -$1.82K ﹤0.01% 2294
2025
Q1 		$3.54K Buy
185
+50
+37% +$1.46K ﹤0.01% 2147
2024
Q4 		$4.86K Hold
135
– – ﹤0.01% 1985
2024
Q3 		$5.72K Sell
135
-174
-56% -$7.38K ﹤0.01% 1903
2024
Q2 		$12.4K Buy
309
+174
+129% +$7.26K ﹤0.01% 1613
2024
Q1 		$4.78K Buy
135
+15
+13% +$402 ﹤0.01% 1940
2023
Q4 		$3.55K Buy
+120
New +$2.49K ﹤0.01% 2024

Other funds holding TNDM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
FGP
Freestone Grove Partners San Francisco, California $14.2B AUM 24.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Private Trust Company's TNDM Position: Q3 2025 in Review

Private Trust Company sold out of Tandem Diabetes Care (TNDM) in Q3 2025, closing a stake of 93 shares — an estimated $1.72K sold.

Private Trust Company first reported a position in TNDM in Q4 2023 and held it in 7 quarters. The position peaked at $12.4K in Q2 2024. 255 funds tracked by Wall St. Rank hold TNDM as of Q3 2025.

  • Private Trust Company reported no remaining Tandem Diabetes Care position as of Q3 2025 after selling out during the quarter.
  • Private Trust Company sold 93 Tandem Diabetes Care shares in Q3 2025, an estimated $1.72K.
  • Private Trust Company first reported a position in Tandem Diabetes Care in Q4 2023 and held it in 7 quarters.
  • Private Trust Company's Tandem Diabetes Care position peaked at $12.4K in Q2 2024.
  • 255 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2025.

Based on Private Trust Company's 13F filing for Q3 2025, filed 15 Oct 2025.